To explore the underlying mechanism that governs the abnormal accumulation of CD73 in immune-suppressive TNBC breast tumors, we have conducted a Tandem Affinity Purification (TAP) coupled with mass spectrometry analyses to identify CD73 interactome (4). This evidence concerns the gene NT5E and breast neoplasm.